Literature DB >> 12231237

Leptin transport across the blood-brain barrier of the Koletsky rat is not mediated by a product of the leptin receptor gene.

William A Banks1, Michael L Niehoff, David Martin, Catherine L Farrell.   

Abstract

Obesity in humans is thought to be caused by a resistance to leptin. Currently, the evidence suggests that this resistance is caused by an impaired transport of leptin across the blood-brain barrier (BBB). It has been assumed that the short form of the leptin receptor, which is a splice variant of the gene which produces all known leptin receptors, is the leptin transporter, but evidence for this is mixed. The Koletsky rat model should provide a clear answer as to whether transport is dependent on leptin receptors as it does not express any functional receptors. The transport of intravenous leptin across the BBB of the Koletsky rat has been found to be greatly reduced, but evidence for a residual of transport makes it unclear whether the transporter is essentially absent or simply saturated by the high levels of leptin in the serum. Here we used the brain perfusion method to negate the influence of serum levels. We found that, whereas no transport of intravenous leptin occurred in the obese Koletsky, the rate of transport was no different from controls when brain perfusion was used. Leptin was transported completely across the BBB, was saturable, and had the same distribution among brain regions as previously found in normal weight mice (highest transport into the hippocampus and hypothalamus, lowest in the frontal cortex). We conclude that a leptin transporter and possibly its gene have yet to be identified and that the short form likely plays a role in the modulation of transport activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12231237     DOI: 10.1016/s0006-8993(02)03013-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  35 in total

1.  Upregulation of astrocytic leptin receptor in mice with experimental autoimmune encephalomyelitis.

Authors:  Xiaojun Wu; Hung Hsuchou; Abba J Kastin; Pramod K Mishra; Weihong Pan
Journal:  J Mol Neurosci       Date:  2012-06-10       Impact factor: 3.444

Review 2.  Cytokine signaling modulates blood-brain barrier function.

Authors:  Weihong Pan; Kirsten P Stone; Hung Hsuchou; Vamshi K Manda; Yan Zhang; Abba J Kastin
Journal:  Curr Pharm Des       Date:  2011-11       Impact factor: 3.116

Review 3.  Concepts for biologically active peptides.

Authors:  Abba J Kastin; Weihong Pan
Journal:  Curr Pharm Des       Date:  2010-10       Impact factor: 3.116

4.  Developmental changes of leptin receptors in cerebral microvessels: unexpected relation to leptin transport.

Authors:  Weihong Pan; Hung Hsuchou; Hong Tu; Abba J Kastin
Journal:  Endocrinology       Date:  2007-11-26       Impact factor: 4.736

Review 5.  Adipokines and the blood-brain barrier.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Peptides       Date:  2007-05-06       Impact factor: 3.750

Review 6.  Mouse models of neurological disorders: a view from the blood-brain barrier.

Authors:  William A Banks
Journal:  Biochim Biophys Acta       Date:  2009-10-29

7.  Gut-brain communications: not the same at all ages.

Authors:  William A Banks
Journal:  Endocrinology       Date:  2010-03       Impact factor: 4.736

8.  Phenotypic effects of an induced mutation of the ObRa isoform of the leptin receptor.

Authors:  Zhiying Li; Giovanni Ceccarini; Michael Eisenstein; Keith Tan; Jeffrey Michael Friedman
Journal:  Mol Metab       Date:  2013-08-04       Impact factor: 7.422

9.  Transport across the blood-brain barrier of pluronic leptin.

Authors:  Tulin O Price; Susan A Farr; Xiang Yi; Serguei Vinogradov; Elena Batrakova; William A Banks; Alexander V Kabanov
Journal:  J Pharmacol Exp Ther       Date:  2010-01-06       Impact factor: 4.030

10.  Unexpected amplification of leptin-induced Stat3 signaling by urocortin: implications for obesity.

Authors:  Weihong Pan; Hong Tu; Hung Hsuchou; Jeremy Daniel; Abba J Kastin
Journal:  J Mol Neurosci       Date:  2007-09-05       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.